TO THE EDITOR: Wesson and coworkers (4) make a commendable attempt at explaining the interesting beneficial effect of alkali administration to ameliorate progressive renal failure. They conclude that patients with moderately reduced renal function already have proton retention, which may have clinical consequences. They demonstrate an alkali-sensitive mechanism in terms of endothelin and aldosterone, which, based on their previous work, could possibly be involved.
We are not told what NAE was after 30 days of oral alkali but without the acute load, but since in CKD1 the NAE is unchanged after the acute load it appears that 30 days of alkali did not change NAE in CKD1. Since blood values were also reported to be unchanged, the physiology of the response noticed during the acute load appears problematic. Insofar as the response was related to acid-base physiology, it seems an anomaly that it only occurs in the acute setting. NAE was measured in the classic way (2) over an 8-h period, but it was not specified which component(s) of NAE caused the difference between the groups or over what time period. Also, since it has previously been pointed out (3) that NAE may be influenced by mechanisms felt to be fundamentally indifferent to the control of pH, the argument for acid retention in CKD2 might have been more plausible if there was a relationship between baseline NAE and the suggested acid retention across the spectrum of estimated glomerualr filtration rate.
In conclusion the strategy to study acid retention in CKD in the paper by Wesson et al. (4) is very interesting. How to model the findings in an optimal way is still a question.
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